Background
Mycoplasmas and ureaplasmas, belonging to the family Mycoplasmataceae and Mollicutes class, are widely distributed in humans, mammals, birds, reptiles, fish, and other vertebrates as well as in plants 12. The genital mycoplasmas represent a complex and unique group of microorganisms that have been associated with a wide array of infectious diseases in adults and infants. The lack of conclusive knowledge regarding the pathogenic potential of Mycoplasma and Ureaplasma spp. in many conditions is due to a general unfamiliarity of physicians and microbiology laboratories with their fastidious growth requirements which makes it difficult to detect them. We also note their high frequency in healthy persons and the poor design of research studies attempting to deepen the association with the disease as regards the mere presence of the organisms in the lower urogenital tract. Besides, we fail to consider the multifactor aspects of diseases; and thus considering these genital mycoplasmas only as a last resort 3. The situation is now changing because of a greater appreciation of the genital mycoplasmas as perinatal pathogens and improvements in laboratory detection, particularly with regard to the development of powerful molecular nucleic acid amplification tests 3.Ureaplasma urealyticum (U. urealyticum), Mycoplasma hominis (M. hominis), Mycoplasma genitalium (M. genitalium) and Ureaplasma parvum (U. parvum) are thought to be associated with genitourinary infections 4567.
Genital ureaplasmas (U. urealyticum and U. parvum) and genital mycoplasmas (M. genitalium and M. hominis) are natural inhabitants of male urethra contaminating the semen during ejaculation. However, these microorganisms particularly U. urealyticum 891011 are potentially pathogenic species playing an etiologic role in both genital infections and male infertility. During the past decade, evidence for damage caused by U. urealyticum to the development and vitality of human embryos has accumulated. In human in vitro fertilization systems, the presence of U. urealyticum in either semen or female genital tract resulted in a decline in pregnancy rate per embryo transfer 1213. The mechanism by which U. urealyticum affects sperm quality has not been yet elucidated. Some investigators did not find any correlation between the presence of U. urealyticum and semen alteration 1114; other works have reported that the presence of U. urealyticum in semen was related to a decrease in sperm concentration 81115, in motility 915, and/or in morphology 16. The dual effect of U. urealyticum on the sperm activity (inhibition of sperm motility at low pHs and increase of sperm velocity at higher pHs, depending on sperm metabolism) has been recently demonstrated 17.
The impact of M. hominis infection on semen parameters and male fertility remains unclear. Hitherto, M. genitalium and U. parvum have seldom been investigated in semen of infertile men.
Genital mycoplasmas and ureaplasmas infections are commonly diagnosed by culture. However, given the time-consuming culture which requires to 2 to 5 days for Ureaplasma spp. and M. hominis and up to 8 weeks for M. genitalium, infectious agents can be detected in less than 8 hours by nucleic acid amplification techniques. Diagnostic methods for the detection of mycoplasmas and ureaplasmas are not commercially yet available. Recently, a PCR-microtiter plate hybridization assay was developed to detect M. genitalium, M. hominis, U. parvum and U. urealyticum in urine samples 8. Thus, we used this PCR-microtiter plate hybridization assay and we tried to detect U. urealyticum, U. parvum, M. hominis and M. genitalium in semen specimens collected from male partners of infertile couples in Tunisia in order to determine the frequency of these microorganisms. We also compared the seminological variables of semen from men who were infected or colonised with genital ureaplasmas and mycoplasmas and from non-infected men.
Genital mycoplasmas and ureaplasmas seem to be widespread among the male partners of infertile couples in Tunisia and Mycoplasma hominis infection of the male genital tract could negatively influence semen quality.
Methods
Subjects
A total of 120 men attending obstetrics and gynecology clinics in Sfax (South of Tunisia) for diagnostic semen analysis were selected to the study after they gave informed consent. All men were undergoing semen analysis as part of a work-up for infertility investigations after failing to conceive with their partner after one year of unprotected intercourse. None of the men showed any symptoms of genitourinary infections and were therefore considered asymptomatic of sexually transmitted disease. The mean duration of infertility was 4.9 years (range 1–19). The mean age of patients was 36.9 years (range 26–58). Prior approval by ethic committee (Association d'Enregistrement et de Lutte Contre le Cancer du Sud Tunisien) was obtained.
Sperm seminological variables
Prior to semen analysis, the men were asked to abstain from sexual intercourse or masturbation for 3–5 days before attending the clinic. All samples for analysis were produced on site and collected into standard containers that had previously been shown not to have any cytotoxic effects on human spermatozoa according to the methods outlined by World Health Organization 18. Immediately after semen production, samples were placed in an incubator and liquefied at 37°C for up to 30 minutes before analysis. Semen analysis was performed according to the WHO criteria to determine the following variables: seminal volume, pH, sperm concentration, vitality, total progressive motility (category [a + b]), rapid progressive motility (category [a]) and morphology (normal forms). Oligospermia was defined by a sperm concentration < 20 × 106/ml, asthenospermia by a sperm motility <50% (category [a + b]), necrospermia by a sperm vitality < 50% and teratospermia by a normal morphology <30%.
Peroxidase staining, a practical and reliable method recommended by WHO for determining leukocytes in the semen, was employed to count and differentiate leukocytes (white blood cells) from immature germ cells 18. Leukocytospermia was indicated by a concentration of leukocytes ≥ 106/mL.
Detection of genital mycoplasmas and ureaplasmas in semen specimens by PCR
For each male patient, 200 μL of semen specimens were used for the detection of genital mycoplasmas and ureaplasmas DNA. An amplification-based method was performed to determine the presence or absence of U. urealyticum, U. parvum, M. hominis and M. genitalium DNA in these samples according to the following protocol.
Extraction of DNA by Cetyltrimethylammonium bromide (CTAB)-phenol-chloroform/isoamyl alcohol method
The precipitates from each 200 μL of semen specimens were harvested by centrifugation at 14,000 g for 20 minutes. The precipitates were treated with 5 μl of proteinase K (20 mg/ml) at 55°C for 2 h in 600 μl of digestion buffer (30 μl of 10% sodium dodecyl sulphate and 570 μl of TE buffer [10 mM Tris-HC1 (pH: 8), 1 mM EDTA]).
After homogenisation, the samples were incubated in a solution of CTAB-NaCl (100 μl of 5 M NaCl and 80 μl of 10% CTAB) for 10 minutes at 65°C, and then mixed with 750 μl of chloroform-isoamyl alcohol (24:1 [vol/vol]) and centrifuged for 15 minutes at 14,000 g in an Eppendorf centrifuge. The aqueous phase was separated, mixed with 750 μl of phenol-chloroform/isoamyl alcohol (25:24:1 [vol/vol/vol]) and centrifuged for 15 minutes at 14,000 g in an Eppendorf centrifuge. The obtained aqueous phase was mixed with an equal volume of isopropanol. The samples were left at -80°C for 1 h and then centrifuged for 15 minutes at 14,000 g. The DNA pellet was washed up once with 70% ethanol, air dried, and dissolved in a final volume of 100 μl of TE buffer.
PCR assay
Initially, the extracted DNA was tested for human β-globin gene to check that there were no PCR inhibitors in the samples. Primers β-GPCO (5'-ACACAACTGTGTTCACTAGC-3') and β-GPCPO (5'-GAAACCCAAGAGTCTTCTCT-3') were used to amplify a 209-bp fragment of the human β-globin gene 19. Samples found to be negative by PCR for β-globin were retested after dilution 10-fold in distilled water. Samples shown to be β-globin positive were then examined for the presence of U. urealyticum, U. parvum, M. hominis and M. genitalium. A forward primer, My-ins (5'-GTAATACATAGGTCGCAAGCGTTATC-3'), and two reverse primers, MGSO-2-Bi (5'-CACCATCTGTCACTCTGTTAACCTC-3') and UGSO-Bi (5'-CACCACCTGTCATATTGTTAACCTC-3'), were used to amplify an approximately 520-bp region of the 16S rRNA gene of mycoplasmas and ureaplasmas 20.
The PCR mixture, which was made up to 50 μl with sterile water, contained 1 × PCR buffer [50 mM Tris-HCl (pH: 8.3), 10 mM KCl, 5.0 mM (NH4)2SO4, 2.0 mM MgCl2]; 0.5 μM My-ins; 0.25 μM (each) MGSO-2-Bi and UGSO-Bi; 0.2 mM (each) dATP, dCTP, and dGTP; 0.6 mM dUTP; 1.25 U of Go Taq DNA polymerase (Promega, France); and 10 μl of prepared DNA solution. PCR was performed using the Gene-Amp PCR System 9700 (Perkin Elmer Cetus) under the following conditions: an initial cycle at 95°C for 5 minutes, followed by 40 cycles of denaturation at 94°C for 30 seconds, annealing at 55°C for 30 seconds, and elongation at 72°C for 45 seconds, with a final cycle at 72°C for 7 minutes. Each run PCR included a positive control (M. hominis PG21) and 2 negative controls (previously negatively tested samples and distilled water). The PCR products were then subjected to hybridization assays.
Hybridization
Amplified products of 520-bp of U. urealyticum, U. parvum, M. hominis and M. genitalium were detected by using molecular hybridization technique in a liquid phase assay (Argene Hybridowell™Universal) with species-specific internal biotinylated probes 20:
Uure-P4-Am (5'-biotin-GGCTCGAACGAGTCGGTGT-3') specific for U. urealyticum,
Upar-P6-Am (5'-biotin-GTCTGCCTGAATGGGTCGGT-3') specific for U. parvum,
Mhom-P10-Am (5'-biotin – GACACTAGCAAACTAGAGTTAG-3') specific for M. hominis,
Mgen-P3-Am (5'-biotin-TCGGAGCGATCCCTTCGGT-3') specific for M. genitalium.
The amplified products were denatured in denaturation solution for 10 minutes and then immobilized to a microtiter plate, DNA-BIND 1 × 8 strip well plates, as described in the manufacturer's instructions. Specific-species capture probe diluted in hybridization solution was added to the wells of each microtiter plate immobilized by the denatured amplicons, and hybridization was carried out at 37°C for 30 minutes. Following hybridization, the wells were washed four times (soaking for 30 seconds) with washing solution. One hundred microliters of ready-to-use conjugate were added per well and incubated for 15 minutes at room temperature. Wells were washed as described above. One hundred microliters of substrate (Tetramethylbenzidine) were added per well and incubated for 30 minutes at room temperature in the darkness. The reaction was stopped by adding 100 μl of stop solution to each well, and the OD at 450 nm was measured.
Samples with an OD value of greater than the cut-off value (OD of negative control + 0.15) + 10% of cut-off value were considered positive, as suggested by the manufacturer.
Statistical analysis
Semen characteristics were compared between ureaplasmas semen-positive and ureaplasmas semen-negative groups, and between mycoplasmas semen-positive and mycoplasmas semen-negative groups. Means were calculated for the separate groups for sample volume, pH, sperm concentration, vitality, rapid progressive motility, total progressive motility, normal morphology and leukocyte count for semen samples.
All the variables were initially inspected for normally distribution, and the sample volume and pH were all found to be approximately normally distributed. Therefore, standard parametric techniques (t-tests) were used to test significance of factors. Because sperm concentration, vitality, rapid progressive motility, total progressive motility, normal morphology and leukocyte count were not normally distributed and nonparametric techniques (Wilcoxon tests) were used to test the significance of the differences between groups regarding these factors. P < 0.05 was considered statistically significant.
Results
Frequency of genital ureaplasmas and mycoplasmas in semen samples
Of 120 semen samples, 23 (19.2%) were positive for genital ureaplasmas and 19 (15.8%) were positive for genital mycoplasmas. U. urealyticum was detected in 18 patients (15%). Thirteen of them had only U. urealyticum, and the rest consist of mixed species (1 U. urealyticum + M. hominis + M. genitalium; 2 U. urealyticum + M. hominis and 2 U. urealyticum + M. genitalium).U. parvum was detected in 5 patients (4.2%). Three of them had only U. parvum and two had mixed species (U. parvum + M. genitalium).M. hominis was detected in 13 patients (10.8%). While nine patients had only M. hominis, the rest had mixed species (1 M. Hominis + U. urealyticum + M. genitalium; 2 M. hominis + U. urealyticum and 1 M. hominis + M. genitalium).M. genitalium was detected in 6 patients (5%). All of them had mixture species listed above. The distribution of detected species of genital ureaplasmas and mycoplasmas from the patients is shown in Table 1.
<p>Table 1</p>
Frequency of genital mycoplasmas and ureaplasmas in semen samples of 120 infertile male patients by PCR-microtiter plate hybridization
Species
Patients N = 120
U. urealyticum only
13 (10.8%)
U. parvum only
3 (2.5%)
M. hominis only
9 (7.5%)
M. genitalium only
-
Mixed infection
8 (6.7%)
U. urealyticum + M. hominis + M. genitalium
1
M. hominis + M. genitalium
1
U. urealyticum + M. hominis
2
U. parvum + M. genitalium
2
U. urealyticum + M. genitalium
2
Relationship between the detection of genital ureaplsmas and mycoplasmas and sperm seminological variables
The analysis of the semen specimens based on seminological variables according to the WHO criteria 18 had shown that 5.8% (7/120) were normal categories and 94.2% (113/120) were abnormal categories. The frequency of genital ureaplasmas and mycoplasmas DNA in semen samples were not significantly different between the normal and abnormal categories (p > 0.05).
The mean values of seminal volume, pH, sperm concentration, sperm vitality, sperm motility, sperm morphology and leukocyte count were not significantly related to the detection of genital ureaplasmas DNA in semen specimens (Table 2).
<p>Table 2</p>
Seminological variables of semen of ureaplasmas-positive and ureaplasmas- negative of 120 infertile men
Ureaplasma Urealyticum
Ureaplasma parvum
Variable
Positive semen (n = 18)
Negative semen (n = 102)
P
#
value
Positive semen (n = 5)
Negative semen (n = 115)
P
#
value
Volume
3.02 ± 0.33
3.41 ± 0.16
0.34*
4.38 ± 0.73
3.31 ± 0.15
0.14*
PH
7.57 ± 0.05
7.62 ± 0.03
0.58 *
7.80 ± 0.20
7.60 ± 0.03
0.19*
Sperm concentration (x106/mL)
34.15 ± 8,88
50.99 ± 6.34
0.40
38.90 ± 2.70
48.87 ± 5.81
0.43
Vitality (%)
64.00 ± 3.63
61.93 ± 2.08
0.91
65.60 ± 8.22
62.04 ± 1.92
0.62
Total progressive motility (category [a + b]) (%)
31.43 ± 3.12
30.16 ± 1.34
0.72
29.00 ± 4.30
30.40 ± 1.27
0.55
Rapid progressive motility (category [a]) (%)
11,79 ± 2,49
9,67 ± 0.82
0.52
9.00 ± 3.67
10.00 ± 0.81
0.85
Morphology (Normal forms) (%)
10.07 ± 1.69
14.05 ± 1.22
0.33
12.50 ± 6.91
13.54 ± 1.10
0.52
Leukocyte count (x106/mL)
0.743 ± 0.156
1.199 ± 0.279
0.053
0.348 ± 0.128
1.165 ± 0.249
0.72
Note: Data are means (± Standard Error)
# Unless indicated, variables were tested by the Wilcoxon rank-sum test.
* Tested by t-test.
The sperm concentration and the percentage of normal forms of spermatozoa in the male partners of infertile couples with M. hominis DNA in semen specimens were significantly lower than that of the male partners without M. hominis DNA (14.14 × 106/mL vs 52.63 × 106/mL;p = 0.007 and 8.56% vs 13.98%. p = 0.03 respectively) (Table 3). The sperm concentration of spermatozoa in the male partners of infertile couples with M. genitalium DNA in semen specimens were significantly lower than that of the male partners without M. genitalium DNA (21.74 × 106/mL vs 49.87 × 106/mL;p = 0.05) (Table 3). The mean values of seminal volume, pH, vitality, motility and leukocyte count were not significantly related either to the detection of genital mycoplasmas DNA or to the detection of ureaplasmas DNA in semen specimens (Table 2, Table 3).
<p>Table 3</p>
Seminological variables of semen of mycoplasmas-positive and mycoplasmas- negative of 120 infertile men
Mycoplasma hominis
Mycoplasma genitalium
Variable
Positive semen (n = 13)
Negative semen (n = 107)
P# value
Positive semen (n = 6)
Negative semen (n = 114)
P# value
Volume
3.31 ± 0.37
3.35 ± 0.16
0.93*
4.32 ± 0.98
3.30 ± 0.14
0.13*
pH
7.45 ± 0.10
7.63 ± 0.03
0.07*
7.50 ± 0.00
7.61 ± 0.03
0.48*
Sperm concentration (x106/mL)
14.14 ± 4.84
52.63 ± 6.10
0.007
21.74 ± 16.20
49.87 ± 5.78
0.051
Vitality (%)
57.67 ± 5.93
62.64 ± 1.96
0.33
41.00 ± 35.00
62.63 ± 1.81
0.57
Total progressive motility (category [a + b]) (%)
26.67 ± 4.41
30.68 ± 1.28
0.30
20.00 ± 20.00
30.53 ± 1.21
0.63
Rapid progressive motility (category [a]) (%)
7.78 ± 2.52
10.16 ± 0.83
0.43
7.50 ± 7.50
10.00 ± 0.79
0.71
Morphology (Normal forms) (%)
8.56 ± 3.2
13.98 ± 1.14
0.03
11.00 ± 4.00
13.55 ± 1.10
0.99
Leukocyte count (x106/mL)
1.153 ± 0.529
1.128 ± 0.261
0.06
0.972 ± 0.307
1.139 ± 0.251
0.09
Note: Data are means (± Standard Error).
# Unless indicated, variables were tested by the Wilcoxon rank-sum test.
* Tested by t-test.
The comparison of the sperm seminological variables between semen with mixed infections and semen without infections and between semen with mixed infections and semen without mixed infections demonstrated no significant differences in the mean values of seminal volume, pH, sperm vitality, sperm motility, sperm morphology and leukocyte count (Table 4). Only the sperm concentration in the semen specimens of infertile men with mixed infection were significantly lower than that of the semen specimens without infections (14.94 × 106/mL vs 55.30 × 106/mL;p = 0.02) (Table 4).
<p>Table 4</p>
Seminological variables of semen with mixed mycoplasmas and ureaplasmas species infections
Variable
Semen with mixed infections (n = 8)
Semen without infections (n = 87)
P#a value
Semen without mixed infections (n = 25)
P
#b
value
Volume
3.74 ± 0.60
3.35 ± 0.17
0.52*
3.23 ± 0.32
0.45*
PH
7.56 ± 0.06
7.63 ± 0.03
0.55*
7.55 ± 0.08
0.95*
Sperm concentration (x106/mL)
14.94 ± 7.27
55.30 ± 7.26
0.02
35.37 ± 6.96
0.064
Vitality (%)
64.50 ± 11.53
62.86 ± 2.19
0.63
59.50 ± 3.76
0.50
Total progressive motility (category [a + b]) (%)
28.75 ± 9.66
30.82 ± 1.44
0.97
28.8 ± 2.28
0.51
Rapid progressive motility (category [a]) (%)
12.50 ± 4.33
10.13 ± 0.89
0.50
8.86 ± 1.83
0.32
Morphology (Normal forms) (%)
12.25 ± 6.97
14.76 ± 1.33
0.34
9.14 ± 1.28
0.91
Leukocyte count (x106/mL)
0.717 ± 0.240
1.239 ± 0.319
0.10
0.886 ± 0.284
0.83
Note: Data are means (± Standard Error).
a Difference of seminological variables between semen with mixed infections and semen without infections.
b Difference of seminological variables between semen with mixed infections and semen without mixed infections.
# Unless indicated, variables were tested by the Wilcoxon rank-sum test.
* Tested by t-test.
Limitations of this study
We couldn't get semen samples from fertile men, so, we have limited our comparison for seminological variables between semen from infected and non-infected infertile men with genital mycoplasmas and ureaplasmas.
Discussion
It is estimated that 15% of male infertility is related to genital tract infection 21. Among infectious microorganisms, U. urealyticum is one of the most common species 1122. Since 1967, the ureaplasmas have been shown as an etiology of male infertility 23, and especially when Friberg and Gnarpe 24 first demonstrated a higher frequency of ureaplasmas in the semen of men with unexplained infertility (76%) compared with fertile men (19%). Previously, U. urealyticum had been differentiated, into biovars 1 and 2. biovar 1 is composed of serovars 1, 3, 6, and 14, and biovar 2 is composed of serovars 2, 4, 5, and 7 to 13 225. In 1999, U. urealyticum biovars 1 and 2 were classified into U. parvum and U. urealyticum, respectively 26. Most of the previous reported studies have discussed the role of ureaplasmas in male infertility without discriminating between U. parvum and U. urealyticum 9141523. In our study, we have used the PCR-microtiter plate hybridization assay that can facilitate the identification of U. urealyticum, U. parvum, M. hominis and M. genitalium in semen specimens. Our results demonstrated that genital mycoplasmas and ureaplasmas seem to be widespread among infertile male patients, as shown respectively by the frequency of 19.2% and 15.8%. These data are comparable with those reported in previous studies 11027. U. urealyticum was the most prevalent species detected (15%) in this study. The frequency of U. urealyticum in the semen samples of male infertile patients in the literature varies from 5 to 42% 910112728. This wide range might be explained by the diversity of detection methods used for characterizing the studied populations.
In our study, U. parvum was detected in 4.2% of semen samples. The frequency of this species was lower than that reported by Knox et al. 17 (4.2% vs 19.2%).
M. hominis has been associated with bacterial vaginosis, pelvic inflammatory disease, postpartum fever, and postabortal fever, as well as a number of gynaecological infections 2029. However, its role in non-gonoccocal urethritis (NGU) and in infertility is rarely investigated 30. The frequency of M. hominis, in our study, was comparable to that reported by Andra-Rocha et al. 5 but higher than that reported by Rosemond et al. 28.
M. genitalium was first isolated in urethral cultures from two men with NGU in 1981 31. Although M. genitalium has been suggested as a cause of human NGU, the precise role of this mycoplasma in the etiology of NGU remains not established because of the immense difficulty in isolating it from clinical samples. More recently, however, PCR-based assays have facilitated the detection of M. genitalium in clinical samples 4 and a significant association has been demonstrated between M. genitalium and NGU 532. Hitherto, M. genitalium has seldom been investigated in semen of infertile men. In our study, the frequency of M. genitalium was higher than that reported by Kjaergaard et al. 33 (5% vs 0.9%). This difference might be explained by the use of different methods for the detection of this bacterium. We have used PCR that is more sensitive than culture and that can facilitate the detection of M. genitalium in clinical samples 20.
In the present study, the frequency of the U. urealyticum was higher than that of M. hominis. U. urealyticum was also detected more often than U. parvum and M. genitalium. These findings were consistent with other studies 102733.
In the literature, mixed species (U.urealyticum + M. hominis) have been found in 7–14% of semen samples of infertile men 2729. In our study, although M. genitalium was not separately isolated among patients, it was detected together with U. urealyticum + M. Hominis in one patient, with M. hominis in one patient, with U. parvum in two patients and with U. urealyticum in two patients.U. urealyticum and M. hominis were observed together in two patients. Thus, eight patients (6.7%) had mixed species and our results are similar to those of previously reported studies 2729. These results show that the hybridization-based microtiter plate assay can be a useful method to detect mixed infection when multiple species of mycoplasmas or ureaplasmas were present in semen specimens.
Previous studies have reported that the presence of mycoplasmas and ureaplasmas in sperm specimens has no real effect on the semen quality, nor on the leukocyte count 1029. Recent investigations seem to show that the presence of mycoplasmas reflects a silent infection rather than infection in infertile patients 30, even though when the attachment and invasiveness towards human sperm cell has been demonstrated in vitro 3435. Reports are controversial about the effects of genital mycoplasmas and ureaplasmas infections or infection on sperm seminological variables 11273637. We have compared semen and first void urine specimens from the 120 infertile men for the detection of genital ureaplasmas and mycoplasmas infections using in-house PCR (unpublished data). We have found a very high concordance (> 95%) and a very good agreement (K > 0.8) between the detection of genital mycoplasmas and ureaplasmas DNA in semen and corresponding first void urine specimens. Several studies have shown that nucleic acid amplification tests performed on first void urine samples are able to detect as many or more infected patients than traditional swabs from the urethra or cervix or semen 3839404142. In some cases, we have found discrepancies between the detection of genital mycoplasmas and ureplasmas DNA in semen and corresponding first void urine specimens. The presence of genital mycoplasmas and ureaplasmas DNA in first void urine samples and its absence in semen specimens may indicate an asymptomatic urethral infection. The detections of genital mycoplasmas and ureaplasmas DNA only in semen may indicate that these organisms are harboured in the epididymis or seminal vesicles.
In the present study, the comparison of the sperm seminological variables of U. urealyticum-positive and U. urealyticum-negative infertile men demonstrated no significant differences in sperm seminological variables, which confirms previous findings 2733. Conversely, a relationship between U. urealyticum and semen characteristics was observed in some literature 113637. The influence or the lack of influence of mycoplasmas and ureaplasmas on seminology may come from the capability of bacterial species to attach to spermatozoa and to affect directly via cellular interactions their vitality, motility, morphology, cellular integrity and their molecular structure or the development of protective immunity to genital infection by the host (population sensitivity to microbial agents) or other host factors.
In our study, a positive correlation was found between sperm morphology and the detection of M. hominis in semen samples of infertile men. Yet, a correlation was reversely observed between sperm concentration and the detection of this organism in semen samples. The sperm concentration (14.14 × 106/mL) was lower than the normal reference of WHO manual (≥ 20 × 106/ml) in semen of M. hominis-positive infertile men and higher (52.63 × 106/mL) in semen of M. hominis-negative infertile men. The present data show that M. hominis may affect sperm concentration and sperm morphology of infertile men. A negative correlation was also found between sperm concentration and the detection of M. genitalium in semen samples of infertile men. Although, the sperm count with the presence of M. genitalium was within a normal range, a decrease in sperm concentration was significant. However, we have failed to demonstrate a correlation between sperm concentration and sperm morphology and the detection of genital ureaplasmas in semen samples. The comparison of the sperm seminological variables between semen with mixed infections and semen without mixed infections or without infections showed that only the sperm concentration in the male partners of infertile couples with mixed infection in semen specimens were significantly lower than that of the male partners without infections. Our findings show that the mixed infections have no additional effect on seminology.
Semen with M. hominis presented a higher mean of leukocytes than semen with negative M. hominis; this difference not was statistically significant. The detected mean (1.153 × 106 leukocytes/mL) was higher than the reference value of the WHO manual (≥ 1 × 106 leukocytes/mL). In contrast, the means of leukocyte count of the positive DNA in semen samples for U. urealyticum, U. parvum and M. genitalium were smaller than the reference value of the WHO manual. In addition, no significant difference was detected among our studied patients. These findings indicate that the presence of mycoplasmas and ureaplasmas in semen is not necessary associated with leukocytospermia, and thus, in spite of potentially pathogenic species. Our results are consistent with previous reports 1036. The unreliability of leukocytospermia levels to predict the presence of genital mycoplasmas and ureaplasmas, when evaluating subfertile men and the absence of leukocytospermia, does not exclude the presence of genital mycoplasmas and ureaplasmas 4344.